Back

Personalised antiplatelet therapy after acute coronary syndrome

20 March 2026 (17:00 - 17:12)
Organised by: Logo
Congress Presentation Part of: State-of-the-art in acute coronary syndromes Acute Coronary Syndromes ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Injectable antiplatelet therapies: what's new?
Professor I. Ahrens (Cologne, DE)
Slides Video
Presentation thumbnail
Granting access for everyone: STEMI reperfusion in low resources
Doctor D. Araiza Garaygordobil (Ciudad de Mexico, MX)
Slides Video
Presentation thumbnail
Targeting inflammation in acute coronary syndrome: daily clinical practice with guideline recommendation or back to clinical trials?
Doctor H. Soeholm (Lund, SE)
Slides Video
Presentation thumbnail
State-of-the-art in acute coronary syndromes - discussion
Video

Access the full session

Session thumbnail
State-of-the-art in acute coronary syndromes

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Antiplatelet therapy in coronary artery disease: a balancing act
thumbnail
Congress Presentation
When and how to escalate antithrombotic therapy beyond aspirin in chronic coronary syndromes
thumbnail
Congress Session
Personalised dual antiplatelet therapy (DAPT) after acute coronary syndromes: difficult decisions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources